Keyphrases
Kidney
100%
Type 2 Diabetic Patients
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Cardiorenal Outcomes
100%
All-cause Mortality
43%
Estimated Glomerular Filtration Rate
31%
Low Risk
25%
Type 2 Diabetes Mellitus (T2DM)
18%
Heart Failure Hospitalization
18%
Cardiovascular Outcomes
18%
Myocardial Infraction
18%
All-cause Hospitalization
12%
Propensity Score Matching
12%
End-stage Kidney Disease
12%
Rate Reduction
12%
Low Incidence
6%
Randomized Controlled Trial
6%
Between-group
6%
Demographic Characteristics
6%
Mortality Rate
6%
Cardiorenal Risk
6%
Health Systems
6%
Risk Types
6%
Outcome-based
6%
Medical Characteristics
6%
Single Component
6%
Maccabi
6%
Diabetes Registry
6%
Patient-initiated
6%
Glucose-lowering Drugs
6%
Kidney Outcomes
6%
Albumin-to-creatinine Ratio
6%
Population Needs
6%
Urinary Albumin
6%
Kidney Disease Improving Global Outcomes
6%
Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
All Cause Mortality
87%
Glomerular Filtration Rate
62%
Apoplexy
37%
Cardiovascular System
37%
Maturity Onset Diabetes of the Young
37%
Heart Failure
37%
End Stage Renal Disease
25%
Urinary System
25%
Randomized Controlled Trial
12%
Population
12%
Creatinine
12%
Nephropathy
12%
Propensity Score Matching
12%